City National Bank’s Haemonetics HAE Stock Holding History

City National Bank’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-25,044	Closed	-$1.05M	–	842
2013 Q4	$1.05M	Buy	25,044 +10,720	+75%	+$441K	0.02%	409
2013 Q3	$571K	Sell	14,324 -402	-3%	-$16.9K	0.01%	487
2013 Q2	$609K	Buy	+14,726	New	+$596K	0.01%	497

Other funds holding HAE

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

City National Bank's HAE Position: Q1 2014 in Review

City National Bank sold out of Haemonetics (HAE) in Q1 2014, closing a stake of 25,044 shares — an estimated $1.05M sold.

City National Bank first reported a position in HAE in Q2 2013 and held it in 3 quarters. The position peaked at $1.05M in Q4 2013. 192 funds tracked by Wall St. Rank hold HAE as of Q1 2014.

City National Bank reported no remaining Haemonetics position as of Q1 2014 after selling out during the quarter.
City National Bank sold 25,044 Haemonetics shares in Q1 2014, an estimated $1.05M.
City National Bank first reported a position in Haemonetics in Q2 2013 and held it in 3 quarters.
City National Bank's Haemonetics position peaked at $1.05M in Q4 2013.
192 funds tracked by Wall St. Rank held Haemonetics as of Q1 2014.

Based on City National Bank's 13F filing for Q1 2014, filed 2 May 2014.